These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prevention of invasive meningococcal disease in the United States. Pelton SI Pediatr Infect Dis J; 2009 Apr; 28(4):329-32. PubMed ID: 19333079 [No Abstract] [Full Text] [Related]
25. Clinical practice. Prevention of meningococcal disease. Gardner P N Engl J Med; 2006 Oct; 355(14):1466-73. PubMed ID: 17021322 [No Abstract] [Full Text] [Related]
26. Epidemic meningococcal disease in sub-Saharan Africa--towards a sustainable solution? Pollard AJ; Maiden MC Lancet Infect Dis; 2003 Feb; 3(2):68-70. PubMed ID: 12560188 [No Abstract] [Full Text] [Related]
27. Increased Risk for Meningococcal Disease Among Men Who Have Sex With Men in the United States, 2012-2015. Folaranmi TA; Kretz CB; Kamiya H; MacNeil JR; Whaley MJ; Blain A; Antwi M; Dorsinville M; Pacilli M; Smith S; Civen R; Ngo V; Winter K; Harriman K; Wang X; Bowen VB; Patel M; Martin S; Misegades L; Meyer SA Clin Infect Dis; 2017 Sep; 65(5):756-763. PubMed ID: 28505234 [TBL] [Abstract][Full Text] [Related]
29. From the Centers for Disease Control and Prevention. Update: Assessment of risk for meningococcal disease associated with the Hajj 2001. JAMA; 2001 Apr; 285(15):1956. PubMed ID: 11336047 [No Abstract] [Full Text] [Related]
30. Epidemiology and meningococcal serogroup distribution in the United States. Hershey JH; Hitchcock W Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868 [No Abstract] [Full Text] [Related]
31. Notes from the field: serogroup C invasive meningococcal disease among men who have sex with men - New York City, 2010-2012. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Jan; 61(51-52):1048. PubMed ID: 23282863 [TBL] [Abstract][Full Text] [Related]
32. Outbreak of invasive meningococcal disease in Goleniow County, northwest Poland, March 2009. Skoczyńska A; Wasko I; Kuch A; Gołebiewska A; Foryś M; Hryniewicz W Euro Surveill; 2010 Aug; 15(34):. PubMed ID: 20807486 [No Abstract] [Full Text] [Related]
33. Opportunities for control of meningococcal disease in the United States. Raghunathan PL; Bernhardt SA; Rosenstein NE Annu Rev Med; 2004; 55():333-53. PubMed ID: 14746525 [TBL] [Abstract][Full Text] [Related]
34. Meningococcal disease: a review on available vaccines and vaccines in development. Bröker M; Fantoni S Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565 [TBL] [Abstract][Full Text] [Related]
35. Meningococcal serogroup B outbreaks and use of 4CMenB vaccine. Rose WE J Am Pharm Assoc (2003); 2014; 54(2):198-201. PubMed ID: 24632933 [No Abstract] [Full Text] [Related]
36. Meningococcal disease in New Zealand. Mills G; Bell A N Z Med J; 2013 Apr; 126(1373):10-1. PubMed ID: 23797072 [No Abstract] [Full Text] [Related]
37. Clinical and epidemiological implications of meningococcal disease. Meredith ; Galwankar S J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134 [TBL] [Abstract][Full Text] [Related]
38. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention. Atkinson B; Gandhi A; Balmer P Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671 [TBL] [Abstract][Full Text] [Related]
39. Neisseria vaccines 2007 - international workshop. Martin D IDrugs; 2007 Jul; 10(7):450-2. PubMed ID: 17642012 [No Abstract] [Full Text] [Related]